Tested Applications
| Positive WB detected in | HeLa cells, mouse serum, mouse skeletal muscle, rat skeletal muscle |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human pancreas cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13064-1-AP targets DNAJB4 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag3756 Product name: Recombinant human DNAJB4 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-337 aa of BC034721 Sequence: MGKDYYCILGIEKGASDEDIKKAYRKQALKFHPDKNKSPQAEEKFKEVAEAYEVLSDPKKREIYDQFGEEGLKGGAGGTDGQGGTFRYTFHGDPHATFAAFFGGSNPFEIFFGRRMGGGRDSEEMEIDGDPFSAFGFSMNGYPRDRNSVGPSRLKQDPPVIHELRVSLEEIYSGCTKRMKISRKRLNADGRSYRSEDKILTIEIKKGWKEGTKITFPREGDETPNSIPADIVFIIKDKDHPKFKRDGSNIIYTAKISLREALCGCSINVPTLDGRNIPMSVNDIVKPGMRRRIIGYGLPFPKNPDQRGDLLIEFEVSFPDTISSSSKEVLRKHLPAS Predict reactive species |
| Full Name | DnaJ (Hsp40) homolog, subfamily B, member 4 |
| Calculated Molecular Weight | 38 kDa |
| Observed Molecular Weight | 38 kDa |
| GenBank Accession Number | BC034721 |
| Gene Symbol | DNAJB4 |
| Gene ID (NCBI) | 11080 |
| RRID | AB_2094422 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UDY4 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for DNAJB4 antibody 13064-1-AP | Download protocol |
| IHC protocol for DNAJB4 antibody 13064-1-AP | Download protocol |
| IP protocol for DNAJB4 antibody 13064-1-AP | Download protocol |
| WB protocol for DNAJB4 antibody 13064-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
DNAJB4 Polyclonal Antibody (13064-1-AP) has 14 citations across the following journals: Acta Neuropathologica, EMBO Journal, Molecular Therapy – Nucleic Acids, Cell Biology and Toxicology, International Journal of Molecular Sciences, Cellular Oncology, Clinical and Experimental Medicine, Journal of Virology, Discovery Oncology, OMICS, International Journal of Clinical and Experimental Pathology, eLife, and International Journal of Biological Sciences.
The research fields cover muscle myopathy/chaperonopathy, diabetes-related circadian cognition, muscular dystrophy therapeutics, hepatocarcinogenesis, blood coagulation, renal/kidney and breast/colorectal cancer biomarkers, hepatitis B, sepsis/immunology, and atherosclerosis/lipid metabolism.
| Species | Application | Title |
|---|---|---|
Acta Neuropathol Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure
| ||
Acta Neuropathol Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4 | ||
EMBO J O-GlcNAcylation of circadian clock protein Bmal1 impairs cognitive function in diabetic mice | ||
Mol Ther Nucleic Acids DNAJB6 isoform specific knockdown: Therapeutic potential for limb girdle muscular dystrophy D1 | ||
Cell Biol Toxicol DNAJB4/HLJ1 deficiency sensitizes diethylnitrosamine-induced hepatocarcinogenesis with peritumoral STAT3 activation | ||
Cell Oncol (Dordr) Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study |









